The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder occurring in response to <i>Aspergillus fumigatus</i> that can complicate the course of asthma and cystic fibrosis. Here we present a case of acute ABPA without central bronchiectasis, a case of chronic active ABPA wi...
Main Authors: | Aoife O’Reilly, Eleanor Dunican |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/1/53 |
Similar Items
-
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
by: Moïse Michel, et al.
Published: (2022-06-01) -
Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis
by: Patience Eschenhagen, et al.
Published: (2021-01-01) -
Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals
by: Richard B. Moss
Published: (2023-01-01) -
Case of seropositive allergic bronchopulmonary aspergillosis in a 10-year-old girl without previously documented asthma
by: Jeong Eun Shin, et al.
Published: (2015-05-01) -
Fever and multilobular mass of the right lung in a young adult with asthma
by: Adamantia Sotiriou, et al.
Published: (2015-12-01)